Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed a consent form agreeing to participate.
- You are 18 years of age or older.
- You have been diagnosed with multiple myeloma that has come back or stopped responding to treatment, and all standard treatment options have already been tried.
- Doctors expect you to live for at least 12 weeks.
- You are generally able to carry out daily activities with little or no limitation (confirm with trial site regarding how this is measured).
- Your blood, liver, and kidney functions are at acceptable levels.
Who may not be able to join:
- You still have significant side effects from previous cancer treatments that have not cleared up (minor hair loss or mild nerve-related symptoms may be acceptable).
- You have an active hepatitis B or hepatitis C infection at certain levels (some people with hepatitis B may still be eligible if they receive antiviral treatment — confirm with trial site).
- You have HIV or AIDS.
- You are pregnant, breastfeeding, or planning to become pregnant or father a child during the trial period.
- You have an active autoimmune disease, though some milder conditions such as vitiligo, well-controlled thyroid issues, mild psoriasis, or insulin-controlled type 1 diabetes may still be acceptable (confirm with trial site).
- You have had another type of cancer in the past 3 years, unless it was certain types of skin cancer, early-stage bladder cancer, or very early non-spreading cancers of the prostate, cervix, or breast.
- Your multiple myeloma has spread to the brain or spinal fluid, or you are showing signs of this.
- You have had an active infection within the 14 days before starting the trial treatment.
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8573330740
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose-limiting toxicity (DLT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.